Differential requirement for p56(lck) in HIV-tat versus TNF-induced cellular responses: Effects on NF-κB, activator protein-1, c-Jun N-terminal kinase, and apoptosis

Journal of Immunology

Volumn 164, Issue 10, 2000, Pages 5156-5166

  Manna, Sunil K ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN P56; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR; DNA BINDING PROTEIN; HYDROGEN PEROXIDE; I KAPPA B; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE LCK; REACTIVE OXYGEN METABOLITE; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CYTOTOXICITY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REPORTER GENE;

APOPTOSIS; DNA-BINDING PROTEINS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAT; GENES, REPORTER; HIV-1; HUMANS; HYDROGEN PEROXIDE; I-KAPPA B PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; LIPOPOLYSACCHARIDES; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034656414     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.10.5156     Document Type: Article

References (51)

1. Jones, K. A. 1993. Tat and the HIV-1 promoter. Curr. Opin. Cell Biol. 5:461.
2. Jeang, K-T., J. Xiao, and E. A. Rich. 1999. Multifaceted activities of the HIV-1 transactivator of the transcription. Tat. J. Biol. Chem. 274:28837.
3. Rautonen J., N. Rautonen, N. L. Martin, and D. W. Wara. 1994. HIV type 1 Tat protein induces immunoglobulin and interleukin 6 synthesis by uninfected peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses 10:781.
4. Sastry K. J., H. R. Reddy, R. Pandita, K. Totpal, and B. B. Aggarwal. 1990. HIV-1 tat gene induces tumor necrosis factor-β (lymphotoxin) in a human B-lymphoblastoid cell line. J. Biol. Chem. 265:20091.
5. + T lymphoid (H9) cell line. AIDS Res. Hum. Retroviruses 11:31.
6. Puri, R. K., and B. B. Aggarwal. 1992. Human immunodeficiency virus type 1 tat gene up-regulates interleukin 4 receptors on a human B-lymphoblastoid cell line. Cancer Res. 52:787.
7. Husain, S. R., P. Leland, B. B. Aggarwal, and R. P. Puri. 1996. Transcriptional upregulation of interleukin-4 receptors by human immunodeficiency virus type 1 tat gene. AIDS Res. Hum. Retroviruses 12:1349.
8. Lotz, M., I. Clark-Lewis, and V. Ganu. 1994. HIV-1 transactivator protein Tat induces proliferation and TGF β expression in human articular chondrocytes. J. Cell Biol. 124:365.
9. Barillari, G., R. Gendelman, R. C. Gallo, and B. Ensoli. 1993. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 90:7941.
10. Ensoli, B., L. Bounaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfield, and R. C. Gallo. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:277.
11. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497.
12. Sastry, K. J., M. C. Marin, P. N. Nehete, K. McConnell, A. K. El-Naggar, and T. J. McDonnell. 1996. Expression of human immunodeficiency virus type 1 tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene 13:487.
13. McCloskey, T. W., M. Ott, E. Tribble, S. A. Khan, S. Teichberg, M. O. Paul, S. Pahwa, E. Verdin, and N. Chirmule. 1997. Dual role of HIV Tat in regulation of apoptosis in T cells. J. Immunol. 158:1014.
14. Dhawan, S., R. K. Puri, A. Kumar, H. Duplan, J-M. Masson, and B. B. Aggarwal. 1997. Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 90:1535.
15. Kumar A., S. Dhawan, A. Mukhopadhyay, and B. B. Aggarwal. 1999. Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-κB. FEBS Lett. 462:140.
16. Demarchi, F., F. d'Adda di Fagagna, A. Falaschi, and M. Giacca. 1996. Activation of transcription factor NF-κB by the Tat protein of human immunodeficiency virus type 1. J. Virol. 70:4427.
17. Conant K., M. Ma, A. Nath, and E. O. Major. 1996. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-κB binding and protein kinase C activity in primary human astrocytes. J. Virol. 70:1384.
18. Kumar, A., S. K. Manna, S. Dhawan, and B. B. Aggarwal. 1998. Human immunodeficiency virus-1 tat protein activates c-Jun N-terminal kinase and activator protein-1. J. Immunol. 161:776.
19. lck. Curr. Top. Microbiol. Immunol. 205:63.
20. Straus, D. B., and A. Weiss. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585.
21. Dutartre, H., M. Harris, D. Olive, and Y. Collette. 1998. The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism. Virology 247: 200.
22. lck in an infant with severe combined immunodeficiency. J. Clin. Invest. 102:421.
23. lck is required for triggering NF-κB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4. J. Virol. 72:6207.
24. Gratton, S., M. Julius, and R. P. Sekaly. 1998. Lck-independent inhibition of T cell antigen response by the HIV gp120. J. Immunol. 161:3551.
25. Rouer, E., F. Brule, and R. Benarous. 1999. A single base mutation in the 5 splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line. Oncogene 18:4262.
26. Manna S. K., H. J. Zhang, T. Ya, L. W. Oberley, and B. B. Aggarwal. 1998. Overexpression of Mn-superoxide dismutase suppresses TNF induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1. J. Biol. Chem. 273:13245.
27. Darnay, B. G., J. Ni, P. A. Moore, and B. B. Aggarwal. 1999. Activation of NF-κB by RANK requires TRAF6 and NF-κB-inducing kinase (NIK): identification of a novel TRAF6 interaction motif. J. Biol. Chem. 274:7724.
28. Manna S. K., A. Mukhopadhyay, N. T. Van, and B. B. Aggarwal. 1999. Silymarin suppresses TNF-induced activation of nuclear transcription factor-κB, c-jun N-terminal kinase and apoptosis. J. Immunol. 163:6800.
29. Baeuerle, P. A., and V. R. Baichwal. 1997. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules Adv. Immunol. 65:111.
30. 2 in NF-κB activation by either cytokine in both primary and transformed endothelial cells. J. Biol. Chem. 272:25941.
31. Imbert, V., R. A. Rupec, L. Antonia, H. L. Pahl, E. B.-M. Traenckner, C. Mueller-Dieckmann, D. Farahifar, B. Rossi, P. Auderger, P. A. Baeuerle, and J.-F. Peyron. 1996. Tyrosine phosphorylation of IκBα activates NF-κB without proteolytic degradation of IκBα. Cell 86:787.
32. Finco, T. S., A. A. Beg, and A. S. Baldwin. 1994. Inducible phosphorylation of IκBγ is not sufficient for its dissociation from NF-κB and in inhibited hy protease inhibitors. Proc: Natl. Acad. Sci. USA 91:11884.
33. Singh, S., B. G. Darney, and B. B. Aggarwal. 1996. Site-specific tyrosine phosphorylation of IκBα negatively regulates its inducible phosphorylalion and degradation. J. Biol. Chem. 271:31049.
34. Nasuhara, Y., I. M. Adcock, M. Catley, P. J. Barnes, and R. Newton. 1999. Differential IκB kinase activation and IκBα degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells. Evidence for additional regulatory steps in κB-dependent transcription. J. Biol. Chem. 274:19965.
35. Karin, M., Z. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240.
36. Hirano, M., S. Osada, T. Aoki, S. Hirai, M. Hosaka, J. Inoue, and S. Ohno. 1996. MEK kinase is involved in tumor necrosis factor α-induced NF-κB activation and degradation of IκBα. J. Biol. Chem. 271:13234.
37. Rath, P. C., and B. B. Aggarwal. 1999. TNF-induced signaling in apoptosis J. Clin. Immunol. 19:350.
38. Hardwick, J. S., and B. M. Sefton. 1997. The activated form of the Lck tyrosine protein kinase in cells exposed to hydrogen peroxide is phosphorylated at both Tyr-394 and Tyr-505. J. Biol. Chem. 272:25429.
39. Manna, S. K., and B. B. Aggarwal. 1999. Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-κB activation and gene expression. J. Immunol. 162:2095.
40. Stancovski, I., and D. Baltimore. 1997. NF-κB activation: the IκB kinase revealed? Cell 91:299.
41. Denny, M. F., H. C. Kaufman, A. C. Chan, and D. B. Straus. 1999. The lck SH3 domain is required for activation of the mitogen-activated protein kinase pathway but not the initiation of T-cell antigen receptor signaling. J. Biol. Chem. 274: 5146.
42. Brenner, B., S. Weinmann, H. Grassme, F. Lang, O. Linderkamp, and E. Gulbins. 1997. L-selectin activates JNK via src-like tyrosine kinases and the small G-protein Rac. Immunology 92:214.
43. Buttke, T. M., and P. A. Sandstrom. 1994. Oxidative stress as a mediator of apoptosis. Immunol. Today 15:7.
44. 2-terminal kinases. J. Biol. Chem. 271: 15703.
45. Manna, S. K., M. T. Kuo, and B. B. Aggarwal. 1999. Overexpression of γ-glutamylcysteine synthetase abolishes tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activator protein-1 Oncogene 18:4371.
46. Belka, C., P. Marini, A. Lepple-Wienhues, W. Budach, A. Jekle, M. Los, F. Lang, K. Schulze-Osthoff, E. Gulbins, and M. Bamberg. 1999. The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation. Oncogene 18:4893.
47. al-Ramadi, B. K., H. Zhang, and A. L. Bothwell. 1998. Cell-cycle arrest and apoptosis hypersusceptibility as a consequence of Lck deficiency in nontransformed T lymphocytes. Proc. Natl. Acad. Sci. USA 95:12498.
48. lck complex and targeting of CD4 to lysosomes. Virology 257:208.
49. Li, C. J., Y. Ueda, B. Shi, L. Borodyansky, Y. Z. Li, and A. B. Pardee. 1997. Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. Proc. Natl. Acad. Sci. USA 94:8116.
50. Goldstein, G. 1999. HIV-1-Tat protein as a potential AIDS vaccine. Nat. Med. 1:960.
51. lck tyrosine kinase by isothiazolones. Arch. Biochem. Biophys. 364:19.